The effectiveness of post-exposure vaccination for protection against infectious disease was explored in a recently published review in the journal Epidemiologic Reviews.
While the effectiveness of pre-exposure vaccination is well known, there appears to be greater uncertainty surrounding the use of vaccines to modify or prevent a disease after exposure. To summarize the evidence surrounding this topic, study authors searched PubMed to obtain clinical trials and observational studies evaluating post-exposure vaccination effects. “Eligible studies were evaluated by definition of exposure, and their attempt at distinguishing pre- and post-exposure effects was rated on a scale of 1-4,” the authors explained.
Of the 4518 articles screened, a total of 45 studies (14 clinical trials and 31 observational studies) were considered eligible and included in the review. Results of the analysis revealed that the strength of post-exposure vaccination effectiveness against secondary attack varied across diseases. Medians for post-exposure effectiveness were reported as the following: 85% for hepatitis A, 85% for hepatitis B, 83% for measles, 67% for varicella, 45% for smallpox, and 38% for mumps. In addition, a review of studies evaluating vaccine effectiveness against fatality showed median efficacies of 100% for rabies vaccine and 63% for smallpox vaccine.
Findings of this review demonstrated that there is a lack of knowledge regarding post-exposure effectiveness of many common vaccines and highlighted the importance of researching this area further. “As evidenced by this report, post-exposure effectiveness has not been fully explored even for common vaccines, and there are several scenarios in which they are important: responding to unpredictable health emergencies, designing new treatments, and interpreting vaccine trials,” the authors concluded. They added, “Therefore, post-exposure effects not only concern innovative treatments for exposed or infected individuals, but could also improve how we anticipate and understand the impact of any vaccine.”
For more information visit academic.oup.com.
This article originally appeared on MPR